Skip to content

A multicenter, single-arm study of the MRI-Guided Laser Interstitial Thermal Therapy (MRgLITT) in Epilepsy

A multicenter, single-arm study of the MRI-Guided Laser Interstitial Thermal Therapy (MRgLITT) in Epilepsy

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2300069513
Enrollment
Unknown
Registered
2023-03-20
Start date
2023-03-25
Completion date
Unknown
Last updated
2023-05-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Epilepsy

Interventions

Test group :Laser ablation

Sponsors

The Second Affiliated Hospital of Medical College of Zhejiang University
Lead Sponsor

Eligibility

Sex/Gender
All
Age
2 Years to 70 Years

Inclusion criteria

Inclusion criteria: 1) Age: 2 to 70 years old (including 2 and 70 years old), male and female; 2) Diagnosed as drug-refractory epilepsy; 3) The type of epileptic seizure was focal seizure; 4) The epileptogenic focus is limited and suitable for surgical treatment; 5) The subjects or their guardians can understand the purpose of the trial, voluntarily sign the informed consent form, and follow the clinical trial plan to cooperate with the examination and follow-up.

Exclusion criteria

Exclusion criteria: 1) MRI contraindication; 2) Change the epilepsy treatment plan within 3 months before operation; 3) There are contraindications for craniotomy; 4) Complicated with progressive nervous system disease; 5) Severe impairment of coagulation function; 6) Those who are in the acute stage of acute infection or chronic infection; 7) Pregnant or lactating women; 8) Those who have participated in clinical trials of other drugs or medical devices within one month before screening; 9) The patients with severe insufficiency of heart, liver and kidney function and the researchers think it is not suitable to participate in this clinical trial; 10) The researcher believes that it is not suitable to participate in this clinical trial.

Design outcomes

Primary

MeasureTime frame
Ablation efficiency;

Secondary

MeasureTime frame
Seizure-free rate;Percent reduction in seizures;Success rate of ablation technology;Quality of life score;Mini-Mental State Examination,MMSE;Evaluation of device performance;Postoperative hospital stay;Operation time;Incidence rate of adverse events and serious adverse events;Occurrence rate of device defects;Intraoperative bleeding volume;Success rate of optical fiber placement in place under software planning;

Countries

China

Contacts

Public ContactZhangJianMing

The Second Affiliated Hospital of Medical College of Zhejiang University

zjm135@vip.sina.com+865713805722695

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026